Retrospective analysis of application of left ventricular active fixation lead in 26 cases

Ying ZHOU,Min-fang BAO,Yu-xing WANG,Hai-yan LIN,Wen-bo ZHANG,Geng XU
DOI: https://doi.org/10.3760/cma.j.issn.1007-6638.2013.06.009
2013-01-01
Abstract:Objective We evaluated the usage of an left ventricular (LV) active fixation lead (Medtronic Attain Starfix4195) in cardiac resynchronization therapy(CRT) implantations.Methods Between July 2010 and August 2012,in 26 patients[16 male,10 female,(68.1±7.7)years,16 dilated cardiomyopathy,5 ischemic cardiomyopathy,5 others],the Starfix4195 lead was used.We observed success rate of implanting the LV lead at the optimal pacing site,and after median follow-up of 10.5 months,and the complications,e.g.lead dislocation,phrenic nerve stimulation and increasing pacing threshold were evaluated.Results Starfix4195 lead implantation was overall successful with 100%,in 24 cases the LV lead was implanted at the optimal pacing site.After a follow-up of over 6 months,21 cases(87.5%)were responsive to CRT while another 3 cases(12.5%) were nonresponse to CRT.After a median follow-up of 10.5 months,the threshold of LV lead remained stable compared to that in surgery [(1.0±0.5) V vs.(1.2±0.7) V,P>0.05],and no dislocation of LV lead or phrenic nerve stimulation was observed.Conclusion The Starfix4195 lead proved to be an important option in CRT implantations,which can fix to the optimal pacing site steadily,thus significantly increasing surgery success rate as well as decreasing complications.
What problem does this paper attempt to address?